Skip to content

A Clinical Trial to Evaluate the Efficacy of a Healthy Meal Plan in Improving Health Biomarkers and Promoting Healthy Weight Management.

A Clinical Trial to Evaluate the Efficacy of a Healthy Meal Plan in Improving Health Biomarkers and Promoting Healthy Weight Management.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07140978
Enrollment
100
Registered
2025-08-26
Start date
2024-11-19
Completion date
2025-06-30
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Diet, Healthy Nutrition

Keywords

Healthy meal plan, Weight management

Brief summary

This is a 16-week, two-arm, hybrid, randomized controlled clinical trial designed to evaluate the effect of the Green Chef Calorie Smart & Brain Health meal plans on health biomarkers and perceived well-being. The study aims to measure improvements in blood lipids, body composition, weight, and blood pressure, as well as subjective health indicators through surveys.

Interventions

DIETARY_SUPPLEMENTGreen Chef Meal Delivery Program

Participants will receive Green Chef meals for lunch and dinner, delivered weekly for 16 weeks. Meals include organic produce, responsibly sourced protein, and nutritionist-approved recipes. Participants will also receive guidelines for preparing healthy breakfasts and will use smart devices to record biomarker data.

Sponsors

Citruslabs
CollaboratorINDUSTRY
Green Chef Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males and females aged 25 years or older. * Participants who struggle with healthy weight management and have a desire to lose weight. * Participants who eat takeout or at restaurants at least four times per week. * Participants not currently using a meal kit. * Participants who are willing to cook meals twice daily for the 16-week study period. * Participants who are willing to cook and consume meals as instructed, fill out regular questionnaires, take regular weight and blood pressure measurements, and attend blood tests at Quest for Baseline and Endline assessments for the 16-week study period. * Participants must not have introduced any new prescription medications, supplements, or herbal remedies targeting weight management within the past three months. * Participants must be willing to discontinue any prescription medications, supplements, or herbal remedies that target weight management for the duration of the trial. * Participants must agree to not introduce any new prescription medications, vitamins, minerals, nutraceuticals, or herbal supplements for the duration of the trial. * Participants must consider themselves in good general health and not have any chronic health conditions that could impact their participation in the study. * Participants must reside in the United States.

Exclusion criteria

* Individuals who have undergone surgeries or invasive treatments in the last six months or have any planned for the duration of the trial. * Individuals who have undergone weight loss surgery. * Individuals who have experienced dramatic weight changes (gain or loss) within the past three months. * Individuals who consider themselves to be chronic dieters or always on a diet (e.g., those who have been dieting or restricting calories for a prolonged period of time or who tend to jump from one diet to the next regularly). * Individuals with a known history of severe digestive disorders, including but not limited to acid reflux, Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), ulcerative colitis (UC), Crohn's disease, or gastrointestinal tract surgeries. * Individuals with a known history of any chronic illness such as hypertension, diabetes, or cancer. * Individuals with any known allergies or hypersensitivities to foods. * Individuals with a history of disordered eating behaviors or an eating disorder. * Individuals who regularly take laxatives, or antacids. * Individuals who regularly take anticoagulants (also referred to as blood thinners). * Individuals with chronic health conditions, including oncological or psychiatric disorders, that could impact participation. * Individuals with known serious allergic reactions requiring the use of an Epi-Pen. * Individuals who are currently pregnant, trying to conceive, or breastfeeding. * Individuals currently participating or planning to participate in another research study within the next 16 weeks. * Individuals with a history of substance abuse. * Individuals with specific dietary restrictions that make consuming the test meals impossible (e.g., pescatarian, vegetarian, vegan, Whole 30, FODMAP). * Anyone who has taken a GLP-1 agonist in the last 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Change in Blood Lipid Biomarkers (LDL, HDL, Triglycerides)Baseline to Week 16Blood lipid levels (LDL, HDL, triglycerides) will be measured at baseline and week 16 via fasting blood draws to evaluate the effect of the Green Chef meal plan on cardiovascular health.
Change in Weight and Body CompositionBaseline, Week 8, Week 16Body weight and composition will be measured using a Withings smart scale at baseline, week 8, and week 16 to assess changes related to the dietary intervention.
Change in Blood PressureBaseline, Week 8, Week 16Systolic and diastolic blood pressure will be measured using a Withings smart blood pressure cuff at baseline, week 8, and week 16 to assess impact of the meal plan on cardiovascular function.

Secondary

MeasureTime frameDescription
Change in Self-Reported Health PerceptionsBaseline, Week 4, Week 8, Week 12, Week 16Participants will complete surveys at 5 time points to assess subjective changes in energy, digestion, eating habits, physical appearance, and overall well-being.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026